ArticleJournal of community hospital internal medicine perspectives2026
Prognostic Utility of Delta-Procalcitonin and Modified Shock Index for Risk Stratification of Sepsis in Acute Care Settings.
Article in Journal of community hospital internal medicine perspectives, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Risk stratification in sepsis remains challenging, and while several scoring systems exist, there is a need for simple tools that can reliably predict outcomes. Aims: To study the role of Delta-Procalcitonin and Modified Shock Index (MSI) in predicting the severity of Multiple Organ Dysfunction Syndrome (MODS)like acute kidney injury, vasopressor requirement, need for mechanical ventilation, coagulopathy and 28 day mortality in sepsis. Methods: This prospective observational study recruited 122 patients with suspected sepsis. Delta-Procalcitonin was calculated by measuring the difference in procalcitonin values at the time of admission and after 48 h. Modified Shock Index (MSI) is calculated by "dividing heart rate by mean arterial pressure (MAP)." Procalcitonin and MSI were assessed by Receiver Operating Characteristic (ROC) curve analysis. Results: There's a statistically significant association between delta procalcitonin and the incidence of AKI (p = 0.035), the vasopressor requirement (p = 0.032), coagulopathy (p = 0.015) and no statistically significant association between delta procalcitonin and the need for renal replacement therapy (RRT) (p = 0.670), the mechanical ventilation requirement (p = 0.310), need for blood products (p = 0.57), number of organ dysfunctions(p = 0.344),and 28 day mortality (p = 0.138). The mortality rate was higher in the MSI ≥1.2 group (18.9%) compared to the MSI <1.2 group (11.5%). Conclusion: Delta: Procalcitonin was associated with predicting the severity of acute kidney injury, vasopressor requirement and coagulopathy. MSI had a statistically significant association with the prediction of vasopressor requirement, coagulopathy, and the number of organ dysfunctions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.